During an AHA press conference, Li explained that each component of the triple-receptor agonist compensates for side effects ...
In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most ...
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...
Increased exposure to artificial light at night is linked to higher stress-related activity in the brain, more inflammation in the arteries, and an increased risk for heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback